Top Markets
Coin of the day
AEON Biopharma, Inc. AEON Biopharma, Inc.

AEON Biopharma, Inc.

AEON
Rank in Stocks #31959
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in... AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Share Price
$0.262
Last synced: 2026-08-17
Market Cap
$11.57M
Change (1 day)
-5.00%
Change (1 year)
-65.30%
Country
US
Trade AEON Biopharma, Inc. (AEON)

Category

Operating Margin for AEON Biopharma, Inc. (AEON)
Operating Margin as of 2026 TTM: 0.00%
According to AEON Biopharma, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for AEON Biopharma, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
0.00% -
KR
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.